![](https://investchronicle.com/wp-content/uploads/2019/06/investchronicle-86-e1579507864228-300x205.png)
What Drove Monopar Therapeutics (MNPR) Stock Up Nearly 9% After-Hours?
After-hours trading on Monday saw shares of Monopar Therapeutics Inc. (NASDAQ: MNPR) rise 8.78% to $2.23 following the release of encouraging clinical-trial data. What data has MNPR provided? Yesterday, Monopar Therapeutics (MNPR) published encouraging findings with MNPR-202 from its ongoing partnership with the National University